Since aPL antibodies are additional CV risk-factors, we investigated the percentage of Tang and EPCs among SLE patients positive for aPL; however, our analysis showed that there was no significant difference in the percentage of circulating Tang and EPC subpopulations (data not shown). The gene discussed is FASLG; the disease is systemic lupus erythematosus.